*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*                                                                     *x*
*x*            Copyright (C) 1990 University of Pennsylvania            *x*
*x*                                                                     *x*
*x*    The data in this file are part of a preliminary version of the   *x*
*x*    Penn Treebank Corpus.  Any research using this corpus or based   *x*
*x*    on it should acknowledge that fact, as well as the preliminary   *x*
*x*    nature of the corpus.                                            *x*
*x*                                                                     *x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*



======================================

[ Allergan/NNP Inc./NNP ]
said/VBD that/IN 
[ two/CD shareholder/NN lawsuits/NNS ]
were/VBD filed/VBN in/IN 
[ a/DT federal/JJ court/NN ]
in/IN 
[ Philadelphia/NNP ]
alleging/VBG 
[ misstatements/NNS ]
of/IN 
[ material/NN facts/NNS ]
in/IN 
[ connection/NN ]
with/IN 
[ the/DT recent/JJ spinoff/NN ]
of/IN 
[ the/DT eye/NN ]
and/CC 
[ skin-care/JJ company/NN ]
./. 

======================================

[ Allergan/NNP ]
,/, 
[ Irvine/NNP ]
,/, 
[ Calif./NNP ]
,/, was/VBD spun/VBN off/IN in/IN 
[ July/NNP ]
from/IN 
[ SmithKline/NNP Beckman/NNP Corp./NNP ]
as/IN 
[ part/NN ]
of/IN 
[ the/DT recent/JJ merger/NN ]
of/IN 
[ SmithKline/NNP ]
and/CC 
[ Beecham/NNP Group/NNP PLC/NNP ]
./. 

[ The/DT two/CD combined/VBN pharmaceuticals/NNS companies/NNS ]
were/VBD renamed/VBN 
[ SmithKline/NNP Beecham/NNP ]
./. 

[ SmithKline/NNP Beecham/NNP ]
and/CC 
[ Gavin/NNP Herbert/NNP ]
,/, 
[ Allergan/NNP 's/POS chairman/NN ]
and/CC 
[ chief/NN executive/NN officer/NN ]
,/, were/VBD named/VBN 
[ defendants/NNS ]
in/IN 
[ the/DT suits/NNS ]
,/, 
[ which/WDT ]
allege/VBP that/IN 
[ false/JJ statements/NNS ]
were/VBD made/VBN or/CC 
[ material/NN facts/NNS ]
were/VBD omitted/VBN about/IN 
[ Allergan/NNP 's/POS business/NN ]
and/CC 
[ prospects/NNS ]
./. 

======================================

[ The/DT suits/NNS ]
seek/VBP 
[ class-action/NN status/NN ]
and/CC 
[ unspecified/JJ damages/NNS ]
./. 

======================================

[ Allergan/NNP ]
denied/VBD 
[ the/DT allegations/NNS ]
and/CC said/VBD 
[ it/PRP ]
will/MD ``/`` vigorously/RB contest/VB 
[ the/DT actions/NNS ]
./. 

''/'' In/IN 
[ Philadelphia/NNP ]
,/, 
[ a/DT spokesman/NN ]
for/IN 
[ SmithKline/NNP Beecham/NNP ]
said/VBD 
[ the/DT company/NN ]
did/VBD n't/RB have/VB 
[ anything/NN ]
to/TO add/VB to/TO 
[ Allergan/NNP 's/POS comment/NN ]
./. 
